Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Cancer Med
; 9(13): 4527-4539, 2020 07.
Article
de En
| MEDLINE
| ID: mdl-32352244
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs du sein
/
Protocoles de polychimiothérapie antinéoplasique
/
Phosphohydrolase PTEN
/
Phosphatidylinositol 3-kinases de classe I
Type d'étude:
Clinical_trials
Limites:
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Langue:
En
Journal:
Cancer Med
Année:
2020
Type de document:
Article
Pays d'affiliation:
Allemagne